NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹83 Cr | ₹122 Cr | ₹231 Cr | ₹170 Cr | ₹260 Cr |
What is the latest Total Debt ratio of NEULAND LABORATORIES ?
Year | Total Debt |
---|---|
Mar2024 | ₹83 Cr |
Mar2023 | ₹122 Cr |
Mar2022 | ₹231 Cr |
Mar2021 | ₹170 Cr |
Mar2020 | ₹260 Cr |
How is Total Debt of NEULAND LABORATORIES Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹83 Cr | -32.10 | |
Mar2023 | ₹122 Cr | -47.39 | |
Mar2022 | ₹231 Cr | 35.71 | |
Mar2021 | ₹170 Cr | -34.44 | |
Mar2020 | ₹260 Cr | - |
Compare Total Debt of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹15,708.3 Cr | -4.3% | 2.9% | 74.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,032.0 Cr | 0.9% | 2.2% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,252.0 Cr | 3.3% | 4.7% | 58% | Stock Analytics | |
CIPLA | ₹124,457.0 Cr | 0.5% | 2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,425.0 Cr | -0.4% | 2.8% | 24.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,152.8 Cr | -0.8% | -0.4% | 0.8% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -4.3% |
2.9% |
74.2% |
SENSEX | 0.9% |
3% |
8.9% |
You may also like the below Video Courses